Mira Pharmaceuticals

Mira Pharmaceuticals | 1,002 followers on LinkedIn. Developing the next-generation FDA-approved novel synthetic THC analog | MIRA1a is being developed to treat anxiety and cognitive decline in the elderly and neuropathic pain without impurities or the adverse side effects of cannabis plant extracts.

MIRA - candlestick chart analysis of MIRA Pharmaceuticals Inc.

MIRA Pharmaceuticals Incs Partnership with MIRALOGX LLC Propels Stock Value Surge - Best Stocks

MIRA Pharmaceuticals Begins U.S. IPO Push (MIRA)

MIRA IPO, MIRA Pharmaceuticals IPO Price, Date, and more

MIRA Pharmaceuticals, Inc. [MIRA] Rings the Nasdaq Opening Bell on Livestream

Maryland Inno - Baltimore cannabis pharmaceutical company plans to go public on Nasdaq

MIRA Pharmaceuticals and MIRALOGX Partner to Revolutionize Depressive Disorder Treatments with Ketamir2 - Best Stocks

Maryland Inno - Baltimore's MIRA Pharmaceuticals raises $8.9 million from IPO

Analysis, Removal, Effects and Risk of Pharmaceuticals in the Water Cycle: Occurrence and Transformation in the Environment (Volume 62) (Comprehensive Analytical Chemistry, Volume 62): Petrovic, Mira, Perez, Sandra, Barcelo, Damia: 9780444626578